Supported by an educational grant from Novo Nordisk, Inc.
The adiposity-based disease of obesity should be treated with the same urgency as any other chronic disease. At a live symposium held in Nashville, Tennessee, 3 experts in the management of obesity reviewed the neurobiological and psychological pathways associated with appetite and weight gain and explained how the interaction of lifestyle management and pharmacotherapy can be leveraged to attain sustainable long-term control of overweight and obesity.
Clinicians with an interest in the management of obesity, including specialist physicians (eg, bariatric specialists and endocrinologists), and primary care physicians, pharmacists, physician assistants (PAs), nurses, nurse practitioners (NPs), and dietitians
After completing the activity, the participant should be better able to:
Describe the complex and heterogeneous mechanisms that contribute to the chronicity of obesity
Identify how pharmacotherapies can address perturbations of the neural and hormonal pathways that regulate appetite and energy balance
Develop evidence-based, individualized treatment approaches, including the incorporation of pharmacotherapy with behavioral therapy, to achieve clinically meaningful and sustainable weight loss
Implement patient-centric strategies to overcome barriers to weight loss, using a shared decision-making approach that destigmatizes obesity and promotes weight loss as a path to improved health
Conflict Of Interest Disclosure Policy
In accordance with the ACCME Standards for Commercial Support, HME requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational activities.
CHAIR Robert F. Kushner, MD, MS Professor of Medicine Northwestern University Feinberg School of Medicine Northwestern Medicine Chicago, IL
Dr. Kushner receives consulting fees from Novo Nordisk.
W. Timothy Garvey, MD Professor, Dept. of Nutrition Sciences Director, UAB Diabetes Research Center University of Alabama at Birmingham Staff Physician and GRECC Investigator Birmingham VA Medical Center Birmingham, AL
Dr. Garvey receives consulting fees from Alexion, AstraZeneca, Janssen, Merck & Co, Inc., and Novo Nordisk, Inc.
Holly R. Wyatt, MD Anschutz Health and Wellness Center University of Colorado Anschutz Medical Campus Aurora, CO
Dr. Wyatt does contracted research for DuPont, GI Dynamic, and Novo Nordisk, Inc.
Accredited Provider Disclosures
Haymarket Medical Education staff involved in the planning and content review of this activity have no relevant financial relationships to disclose.
The independent content reviewers have no relevant financial relationships to disclose.
AMA PRA Category 1 Credit(s)TM
Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Haymarket Medical Education designates this enduring material for a maximum of 1.50 AMA PRA Category 1 CreditsTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Additional Credit Information
Physician Assistant Continuing Education AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.50 Category 1 Credit for completing this activity.
Nurse Practitioner Continuing Education The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Disclosure of Unlabeled Use
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Haymarket Medical Education or Novo Nordisk, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.